Posted 19 December 2014 By Alexander Gaffney, RAC The US Food and Drug Administration (FDA) is no longer considering the use of aerial drones to help assist its on-site inspections of facilities, less than 24 hours after initially saying feasibility studies were in the works. As first reported by Regulatory Focus, on 16 December 2014 […]